SUMMARY
Including Constellation Brands, these are four NYSE listed industry leading companies that are not only diversified, pay a dividend, but are slowly positioning themselves to ensure they are leaders once domestic federal prohibition comes to an end. That end may be sooner than some realize depending on how the final outcome of court rulings such as this recent NJ ruling for a review of the Schedule 1 classification.
The four companies listed either have international reach or can do so with ease such as SMG. We know from past content how the Canadian industry is progressing and Canada is often referred to as the global leader. But what about in Europe? This publication provides a nice summary.
The FDA also recently warned those that produce hemp and marijuana products against making false or unproven claims with respect to the effectiveness in treating or curing cancer. This is important as it is an acknowledgement of such products and is bringing their governance in line with that of other drugs and food with respect to such claims.
Will investing in the US industry directly be as rewarding as our last month’s “buy Canada” theme? The time horizon is much longer for the US strategy of course but when one sees Fortune 500 companies in the space more and more and other larger companies restructuring their business models – the end of prohibition just may be on the horizon. Until then, CannaInvestor Magazine will be right there with its industry leading, pioneering, and successful content including strategies and stock pick lists. We will always be connecting the dots so you don’t have to and turning green into gold. Until next time, invest long and prosper and have a wonderful Thanksgiving.
Is investing in the legal cannabis industry even more ideal than before? You decide and in this case … Bull is good!
Editor
74
Case Studies